Mutations in TP53 occur commonly in the majority of human tumors and confer aggressive tumor phenotypes. including metastasis and therapy resistance. CB002 and structural-analogs restore p53 signaling in tumors with mutant-p53 but we find that unlike other xanthines such as caffeine. pentoxifylline. https://www.aitsglobal.com/product-category/bundle/